SCHEMBL4354935

SCHEMBL4354935

O=C1N=C(N2CCN(c3nsnc3Cl)CC2)SC1=Cc1cccc(Oc2ccccc2)c1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.53
ALDH1A1 P00352 3/20 0.52
MAPT P10636 1/20 0.49
HTT P42858 1/20 0.49
KMT2A Q03164 1/20 0.49
HPGD P15428 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
ENPP2 Q13822 3/20 0.48
DCTPP1 Q9H773 1/20 0.46
GRIN1 Q05586 3/20 0.45
GRIN2B Q13224 3/20 0.45
AKR1B1 P15121 1/20 0.45
MCHR1 Q99705 1/20 0.44
MMP3 P08254 1/20 0.44
MMP13 P45452 1/20 0.44
AVPR1A P37288 1/20 0.44
GPR18 Q14330 2/20 0.43
HDAC1 Q13547 1/20 0.43
CNR1 P21554 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4354933 1.00 ALOX5 (0.53) ALOX5ALDH1A1MAPTHTTKMT2A
SCHEMBL4354159 0.92 ALDH1A1 (0.55) ALOX5ALDH1A1MAPTHTTKMT2A
SCHEMBL4354154 0.92 ALDH1A1 (0.55) ALOX5ALDH1A1MAPTHTTKMT2A
SCHEMBL4348506 0.89 GRIN1 (0.50) ALDH1A1MAPTHTTKMT2AHPGD
SCHEMBL4348507 0.89 GRIN1 (0.50) ALDH1A1MAPTHTTKMT2AHPGD
SCHEMBL4359222 0.85 ENPP2 (0.53) ALDH1A1MAPTHTTKMT2AENPP2
SCHEMBL4359220 0.85 ENPP2 (0.53) ALDH1A1MAPTHTTKMT2AENPP2
SCHEMBL4358669 0.84 ENPP2 (0.54) ALDH1A1MAPTHTTKMT2AHPGD
SCHEMBL4348029 0.84 ENPP2 (0.54) ALDH1A1MAPTHTTKMT2AHPGD
SCHEMBL4349885 0.82 GRIN1 (0.67) ALOX5ALDH1A1MAPTHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
EP-1890695-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2008-02-27 EP claimed
WO-2006122777-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2006-11-23 WO claimed
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP disclosed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed
EP-1890695-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2008-02-27 EP disclosed
WO-2006122777-A2 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS Grünenthal GmbH (DE) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 ALOX5 2623/4885ALDH1A1 284/4885MAPT 1470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.